Keratin 18 phosphorylation as a progression marker of chronic hepatitis B

Virology Journal

Volumn 7, Issue , 2010, Pages

  Shi, Ying ^a,b   Sun, Shihui ^a   Liu, Yali ^b   Li, Junfeng ^a   Zhang, Tong ^b   Wu, Hao ^b   Chen, Xinyue ^b   Chen, Dexi ^b   Zhou, Yusen ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CYTOKERATIN 18; SERINE DERIVATIVE; KRT18 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; HEPATITIS B; HISTOPATHOLOGY; HUMAN; LIVER CELL; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; VIRUS CARRIER; VIRUS INFECTION; LIVER; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PROGNOSIS;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

BIOLOGICAL MARKERS; HEPATITIS B, CHRONIC; HUMANS; KERATIN-18; LIVER; PHOSPHORYLATION; PROGNOSIS;

EID: 77950905824     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-70     Document Type: Article

References (30)

1. Keratins, Guardians of the liver. MB Omary NO Ku DM Toivola, Hepatology 2002 35 251 257 10.1053/jhep.2002.31165 11826396
2. 'Hard' and 'soft' principles defining the structure, function and regulation of keratin intermediate filaments. PA Coulombe MB Omary, Curr Opin Cell Biol 2002 14 110 122 10.1016/S0955-0674(01)00301-5 11792552
3. Keratin mediated resistance to stress and apoptosis in simple epithelial cells in relation to health and disease. N Marceau A Loranger S Gilbert N Daigle S Champetier, Biochem Cel Biol 2001 79 543 555 10.1139/bcb-79-5-543 (Pubitemid 33702324)
4. Serum levels of keratin-18 fragments [tissue polypeptide-specific antigen (TPS)] are correlated with hepatocyte apoptosis in alcoholic hepatitis. A Gonzalez-Quintela I Abdulkader J Campos L Fernandez-Hernandez S Lojo, Dig Dis Sci 2009 54 648 653 10.1007/s10620-008-0371-2 18618253
5. Keratin-18 as a marker of steatohepatitis. A Gonzalez-Quintela S Lojo E Otero LF Perez, Hepatology 2006 44 27 33 16799979
6. Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis. Y Yilmaz E Dolar E Ulukaya S Akgoz M Keskin M Kiyici S Aker A Yilmaztepe S Gurel M Gulten SG Nak, World J Gastroenterol 2007 13 837 844 17352011
7. Total and caspase-cleaved cytokeratin 18 in chronic cholecystitis: A prospective study. C Simopoulos AK Tsaroucha B Asimakopoulos A Giatromanolaki P Gavriilidis A Polychronidis A Karaiannakis, BMC Gastroenterol 2008 8 14 18 10.1186/1471-230X-8-14 18460214
8. Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection. GV Papatheodoridis E Hadziyannis E Tsochatzis N Chrysanthos A Georgiou G Kafiri S Manolakopoulos DG Tiniakos I Giannousis EK Manesis AJ Archimandritis, Gut 2008 57 500 506 10.1136/gut.2007.123943 18025069
9. Keratin-dependent, epithelial resistance to tumor necrosis factor-induced apoptosis. C Caulin CF Ware TM Magin RG Oshima, J Cell Biol 2000 149 17 22 10.1083/jcb.149.1.17 10747083
10. Simple epithelium keratins 8 and 18 provide resistance to Fas-mediated apoptosis. The protection occurs through a receptor-targeting modulation. S Gilbert A Loranger N Daigle N Marceau, J Cell Biol 2001 154 763 773 10.1083/jcb.200102130 11514590
11. Keratin mutation in transgenic mice predisposes to Fas but not TNF-induced apoptosis and massive liver injury. NO Ku RM Soetikno MB Omary, Hepatology 2003 37 1006 1014 10.1053/jhep.2003.50181 12717381
12. Keratin attenuates tumor necrosis factor-induced cytotoxicity through association with TRADD. H Inada I Izawa M Nishizawa E Fujita T Kiyono T Takahashi T Momoi M Inagaki, J Cell Biol 2001 155 415 426 10.1083/jcb.200103078 11684708
13. Keratin binding to 14-3-3 proteins modulates keratin filaments and hepatocyte mitotic progression. NO Ku S Michie EZ Resurreccion RL Broome MB Omary, Proc Natl Acad Sci USA 2002 99 4373 4378 10.1073/pnas.072624299 11917136
14. Keratins modulate hepatic cell adhesion, size and G1/S transition. L Galarneau A Loranger S Gilbert N Marceau, Exp Cell Res 2007 313 179 194 10.1016/j.yexcr.2006.10.007 17112511
15. Mutation of a major keratin phosphorylation site predisposes to hepatotoxic injury in transgenic mice. NO Ku SA Michie RM Soetikno EZ Resurreccion RL Broome MB Omary, J Cell Biol 1998 143 2023 2032 10.1083/jcb.143.7.2023 9864372
16. 'Heads and tails' of intermediate filament phosphorylation: multiple sites and functional insights. MB Omary NO Ku GZ Tao DM Toivola J Liao, Trends Biochem Sci 2006 31 383 394 10.1016/j.tibs.2006.05.008 16782342
17. Keratin 8 and 18 hyperphosphorylation is a marker of progression of human liver disease. DM Toivola NO Ku EZ Resurreccion DR Nelson TL Wright MB Omary, Hepatology 2004 40 459 466 10.1002/hep.20277 15368451
18. Hepatocyte cytokeratins are hyperphosphorylated at multiple sites in human alcoholic hepatitis and in a mallory body mouse model. C Stumptner MB Omary P Fickert H Denk K Zatloukal, Am J Pathol 2000 156 77 90 10623656
19. Mallory bodies revisited. H Denk C Stumptner K Zatloukal, J Hepatol 2000 32 689 702 10.1016/S0168-8278(00)80233-0 10782920
20. The keratin cytoskeleton in liver diseases. K Zatloukal C Stumptner A Fuchsbichler F Peter L Carolin T Michael D Helmut, J Pathol 2004 204 367 376 10.1002/path.1649 15495250
21. Mallory body formation in primary biliary cirrhosis is associated with increased amounts and abnormal phosphorylation and ubiquitination of cytokeratins. P Fickert M Trauner A Fuchsbichler C Stumptner K Zatloukal H Denk, J Hepatol 2003 38 387 394 10.1016/S0168-8278(02)00439-7 12663227
22. Heat shock protein 70 expression, keratin phosphorylation and Mallory body formation in hepatocytes from griseofulvin-intoxicated mice. M Fausther L Villeneuve M Cadrin, Comp Hepatol 2004 3 5 21 10.1186/1476-5926-3-5 15307891
23. Cellular immune responses against hepatitis C virus. MJ Koziel, Clin Infect Dis 2005 41 Suppl 1 25 31 10.1086/429492 (Pubitemid 40863721)
24. Dysregulation of apoptosis in hepatocellular carcinoma cells. F Isabel, World J Gastroenterol 2009 15 513 520 10.3748/wjg.15.513 19195051
25. Apoptosis in liver disease. M Schuchmann PR Galle, Eur J Gastroenterol Hepatol 2001 13 785 790 10.1097/00042737-200107000-00005 11474307 (Pubitemid 32656591)
26. TP53 and liver carcinogenesis. F Staib SP Hussain LJ Hofseth XW Wang CC Harris, Hum Mutat 2003 21 201 216 10.1002/humu.10176 12619106
27. Infectious and Parasitic Disease, and Hepatology Branches, Prevention and treatment of viral hepatitis. Chinese Medical Association, Chin J Hepatol 2000 8 324 329
28. Histological grading and staging of chronic hepatitis. K Ishak A Baptista L Bianchi F Callea J De Groote F Gudat H Denk V Desmet G Korb RN MacSween MJ Phillips BG Portmannl H Paulsen PJ Scheuer M Schmid H Thaler, J Hepatol 1995 22 696 699 10.1016/0168-8278(95)80226-6 7560864
29. Implications of intermediate filament protein phosphorylation. NO Ku J Liao CF Chou MB Omary, Cancer Metastasis Rev 1996 15 429 444 10.1007/BF00054011 9034602 (Pubitemid 27067164)
30. Keratin 8/18 breakdown and reorganization during apoptosis. S Bert H Mieke K Wendy B Maartje M Stephan PGL Mathie N Marius B Viveka B Peter B Bertil EB Lane MB Omary J Hans CSR Frans, Exp Cell Res 2004 297 11 26 10.1016/j.yexcr.2004.02.019 15194421